| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 47.861 | 47.899 | 47.889 | 40.711 | 6.378 | 7.618 | 7.750 | 7.153 | 8.008 | 9.601 |
| Total Income - EUR | 51.028 | 48.884 | 49.310 | 42.782 | 6.386 | 7.618 | 7.750 | 7.160 | 8.016 | 9.601 |
| Total Expenses - EUR | 14.034 | 14.100 | 20.531 | 22.296 | 2.875 | 2.732 | 2.918 | 3.261 | 3.493 | 3.500 |
| Gross Profit/Loss - EUR | 36.994 | 34.784 | 28.778 | 20.485 | 3.511 | 4.886 | 4.832 | 3.899 | 4.523 | 6.101 |
| Net Profit/Loss - EUR | 35.463 | 33.317 | 27.377 | 19.265 | 3.319 | 4.657 | 4.605 | 3.684 | 3.799 | 5.125 |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cyopsil Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 263.604 | 226.655 | 219.785 | 44.270 | 42.287 | 40.381 | 38.406 | 37.442 | 37.578 | 36.225 |
| Current Assets | 67.416 | 103.284 | 95.322 | 14.765 | 19.922 | 24.350 | 29.582 | 35.362 | 40.609 | 46.644 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.004 | 3.963 | 7.967 | 4.206 | 3.882 | 4.072 | 4.244 | 6.498 | 5.085 | 5.057 |
| Cash | 63.412 | 99.321 | 87.354 | 10.560 | 16.040 | 20.277 | 3.330 | 1.772 | 8.513 | 4.727 |
| Shareholders Funds | 326.317 | 321.206 | 310.394 | 58.191 | 60.384 | 63.896 | 67.085 | 70.978 | 74.562 | 79.270 |
| Social Capital | 2.812 | 2.783 | 2.736 | 2.686 | 2.634 | 2.584 | 2.527 | 2.535 | 2.527 | 2.513 |
| Debts | 689 | 8.733 | 655 | 463 | 1.229 | 179 | 252 | 1.827 | 3.625 | 3.599 |
| Income in Advance | 4.014 | 4.019 | 4.057 | 381 | 597 | 655 | 651 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Cyopsil Srl